Lipophilic toxicity from the marine dinoflagellate Karenia brevisulcata: use of the brevetoxin neuroblastoma assay to assess toxin presence and concentration

Toxicon. 2005 Sep 15;46(4):441-5. doi: 10.1016/j.toxicon.2005.06.007.

Abstract

A method for assessing the presence and concentration of a major toxin produced by Karenia brevisulcata has been developed, based on the neuroblastoma assay for brevetoxins. This cytotoxicity assay, coupled with observations of the dose-response relationship and of changes in cellular morphology during the assay gave a characteristic toxin 'signature'. This signature was consistent whether the toxicity was assessed in extracts of shellfish, seawater samples, uni-algal cultures of K. brevisulcata, or in partially purified toxin samples. Using this method it was possible to confirm the presence of this toxicity during a mixed Karenia bloom, and infer that K. brevisulcata toxin (KBT) was the probable cause of the fish and shellfish mortality observed at that time. The neuroblastoma assay thus provides a solution to the problem of confirming the presence of KBT in suspected K. brevisulcata events, even in the absence of a known toxin structure.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Assay
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Dinoflagellida / chemistry*
  • Dose-Response Relationship, Drug
  • Marine Toxins / analysis*
  • Marine Toxins / isolation & purification*
  • Marine Toxins / toxicity
  • Tetrazolium Salts
  • Thiazoles
  • Toxicity Tests / methods*

Substances

  • Marine Toxins
  • Tetrazolium Salts
  • Thiazoles
  • thiazolyl blue